Literature DB >> 9230699

Backwards signing and ASL syllable structure.

R B Wilbur1, L Petersen.   

Abstract

A recurrent question raised by the study of signed languages concerns the linguistic effect of the modality in which the language is produced. Is the modality difference between speech and sign reflected merely in the nature of the phonetic features that map into production and perception, or is it the case that there might be higher level organizational differences between the two linguistic modalities? The present study addresses the nature of the modality effect inside the syllable, namely whether syllables in ASL display evidence of segmental composition. Data from backwards signing are presented to demonstrate that the phonological representations that must be available to signers when they perform backwards signing tasks cannot be adequately represented with the current models that posit segmental composition of ASL syllables. Instead, it is argued that it is sufficient to make reference to distinctive features, in syllable initial and syllable final positions, and that there is no support for any further internal segmental divisions.

Mesh:

Year:  1997        PMID: 9230699     DOI: 10.1177/002383099704000104

Source DB:  PubMed          Journal:  Lang Speech        ISSN: 0023-8309            Impact factor:   1.500


  4 in total

1.  Effects of Video Reversal on Gaze Patterns during Signed Narrative Comprehension.

Authors:  Rain Bosworth; Adam Stone; So-One Hwang
Journal:  J Deaf Stud Deaf Educ       Date:  2020-05-30

2.  Productive reduplication in a fundamentally monosyllabic language.

Authors:  Ronnie B Wilbur
Journal:  Lang Sci       Date:  2009

3.  Rapid development of perceptual gaze control in hearing native signing Infants and children.

Authors:  Rain G Bosworth; Adam Stone
Journal:  Dev Sci       Date:  2021-03-02

4.  Amodal aspects of linguistic design.

Authors:  Iris Berent; Amanda Dupuis; Diane Brentari
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.